Phase 2 Study of Yimitasvir Phosphate Capsules

Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection

NCT02346721 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3

NCT02551861 ·Status: WITHDRAWN ·Phase: PHASE2

Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure

NCT03549832 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection

NCT02480712 ·Status: COMPLETED ·Phase: PHASE3

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

NCT02482077 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

NCT02607735 ·Status: COMPLETED ·Phase: PHASE3

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

NCT02781571 ·Status: COMPLETED ·Phase: PHASE2

Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

NCT02032901 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

NCT01826981 ·Status: COMPLETED ·Phase: PHASE2

A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without Cirrhosis

NCT01749150 ·Status: COMPLETED ·Phase: PHASE2

The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China

NCT04997564 ·Status: UNKNOWN ·Phase: PHASE4

SOF Plus DCV in Treating Chinese Treatment-experienced HCV Patients

NCT02473211 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Participants With Chronic HCV

NCT02671500 ·Status: COMPLETED ·Phase: PHASE3

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

NCT03074331 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection

NCT02074514 ·Status: COMPLETED ·Phase: PHASE3

Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic HCV Infection

NCT02201940 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis

NCT04112303 ·Status: COMPLETED ·Phase: PHASE3

Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

NCT01808248 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

NCT02021643 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

NCT01909804 ·Status: COMPLETED ·Phase: PHASE2

Safety of Sofosbuvir ,Daclatasvir in HCV Patients and RAVS in Resistent and Relapsed Cases

NCT03572140 ·Status: UNKNOWN

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

NCT01965535 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

NCT02556086 ·Status: WITHDRAWN ·Phase: PHASE2

Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection

NCT02349048 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection

NCT02722837 ·Status: COMPLETED ·Phase: PHASE3